$29.98
-0.94-3.04%
가까이에: Sep 18, 5:00 PM EST
$30.20
0.220.73%
시간외: 6:26 PM EST
Benzinga
Benzinga
Benzinga
토요일, 9월 19
Caris Life Sciences Inc
CAINASDAQ
Caris Life Sciences Earnings & Forecasts
Caris Life Sciences (CAI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Caris Life Sciences Guidance
Caris Life Sciences (CAI)는 8월 5, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $1.03B - $1.04B 범위로 예상했습니다.
이전 가이던스와 비교하여 Caris Life Sciences는 매출 전망치를 이전 범위인 상향 조정됨에서 $1B - $1.02B로 상향 조정했습니다.
Caris Life Sciences은 7과 8월 12, 2025 사이에 8월 5, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 4 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.02 | $0.07 | $-0.11 |
| Actual | $0.00 | $0.00 | $0.28 | $0.08 |
| Surprise | -100.0% | +100.0% | +300.0% | +172.7% |
| Revenue | ||||
| Estimate | $237.0M | $209.5M | $280.9M | $173.7M |
| Actual | $263.7M | $216.2M | $292.9M | $216.8M |
| Surprise | +11.3% | +3.19% | +4.27% | +24.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.03 | $0.11 | $0.03 | $0.10 |
| Revenue | ||||
| Consensus | $254.7M | $292.9M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved